Lazar, A.; Popa, A.M.; Orlov-Slavu, C.; Cotan, H.-T.; Iaciu, C.I.; Olaru, C.M.; Schreiner, O.D.; Ciobanu, R.C.; Nitipir, C.
The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer. Medicina 2024, 60, 1290.
https://doi.org/10.3390/medicina60081290
AMA Style
Lazar A, Popa AM, Orlov-Slavu C, Cotan H-T, Iaciu CI, Olaru CM, Schreiner OD, Ciobanu RC, Nitipir C.
The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer. Medicina. 2024; 60(8):1290.
https://doi.org/10.3390/medicina60081290
Chicago/Turabian Style
Lazar, Alexandra, Ana Maria Popa, Cristina Orlov-Slavu, Horia-Teodor Cotan, Cristian Ion Iaciu, Cristina Mihaela Olaru, Oliver Daniel Schreiner, Romeo Cristian Ciobanu, and Cornelia Nitipir.
2024. "The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer" Medicina 60, no. 8: 1290.
https://doi.org/10.3390/medicina60081290
APA Style
Lazar, A., Popa, A. M., Orlov-Slavu, C., Cotan, H.-T., Iaciu, C. I., Olaru, C. M., Schreiner, O. D., Ciobanu, R. C., & Nitipir, C.
(2024). The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer. Medicina, 60(8), 1290.
https://doi.org/10.3390/medicina60081290